The combination of panobinostat and olaparib demonstrated synergistic effects, including reduced tumor burden and proliferation, increased tumor apoptosis and DNA damage, enhanced infiltration of CD8+ T cells into the tumor, and decreased expression of m2-like macrophage markers [41]. The gene discussed is CD8A; the disease is neoplasm.